An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024.
Humans
France
/ epidemiology
Parvovirus B19, Human
/ isolation & purification
Disease Outbreaks
Adult
Female
Male
Child
Parvoviridae Infections
/ epidemiology
Immunoglobulin M
/ blood
Adolescent
Child, Preschool
Middle Aged
Antibodies, Viral
/ blood
Erythema Infectiosum
/ epidemiology
Young Adult
Infant
Aged
France
Parvovirus B19
laboratory surveillance
mortality
outbreak
syndromic surveillance
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
medline:
21
6
2024
pubmed:
21
6
2024
entrez:
21
6
2024
Statut:
ppublish
Résumé
From April 2023 to May 2024, an unusual epidemic of parvovirus B19 (B19V) infections occurred in France. The number of B19V IgM-positive serologies was four times higher than in the previous epidemic in 2019. Clinical data from emergency networks corroborated this observation. Morbidity and mortality consequences were observed in children through all data sources. In adults, the increase was only observed in laboratory-confirmed data. Physicians and decisionmakers should be informed in order to better prevent, diagnose and manage at-risk patients.
Identifiants
pubmed: 38904112
doi: 10.2807/1560-7917.ES.2024.29.25.2400339
doi:
Substances chimiques
Immunoglobulin M
0
Antibodies, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM